Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • WUXI PHARMATECH CAYMAN INC Financial Overview

  • Income Statement: WX
      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 253.48 M 135.20 M 118.28 M 46.66%
    Gross Profit 96.34 M 62.86 M 33.48 M 34.76%
    Net Income Before Extra Items/Preferred Div -64.20 M 33.90 M -98.11 M 152.81%
    Operating Income 39.57 M 30.19 M 9.38 M 23.69%
    View Full Report

  • Cash Flow: WX
      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -5.55 M 180.49 M -186.03 M 3,352.44%
    Net Cash Flow - Investing 215.17 M 44.15 M 171.01 M 79.48%
    Net Cash Flow/Operating Activities 60.66 M 65.23 M -4.57 M -7.53%
    View Full Report

  • Balance Sheet: WX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 327.59 M 343.31 M -15.72 M -4.80%
    Total Liabilities 94.90 M 90.38 M 4.51 M 4.76%
    Shareholders Equity 230.88 M 251.40 M -20.52 M -8.89%
    View Full Report

  • Key Ratios / Statistics: WX

    • Valuation

      Price/Earnings (TTM) —
      Price/Sales (TTM) —
      Price/Book (MRQ) 7.50
      Price/Cash Flow (TTM) 20.37

    • Profitability

      Gross Margin 38.01
      Operating Margin 15.61
      Profit Margin -25.33

    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) —

    • Financial Strength

      Quick Ratio (MRQ) 1.85
      Current Ratio (MRQ) 1.74
      Long Term Debt-to-Equity (MRQ) 15.42

    • Management Effectiveness

      Return on Equity (TTM) —
      Return on Assets (TTM) -18.74
      Return on Investments (TTM) -21.79
    View All Key Ratios